Cargando…
Waldenstrom macroglobulinemia: prognosis and management
Waldenstrom macroglobulinemia (WM) is a B-cell lymphoplasmacytic lymphoma characterized by monoclonal immunoglobulin M protein in the serum and infiltration of bone marrow with lymphoplasmacytic cells. Asymptomatic patients can be observed without therapy. First-line therapy should consist of the mo...
Autores principales: | Oza, A, Rajkumar, S V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382666/ https://www.ncbi.nlm.nih.gov/pubmed/25815903 http://dx.doi.org/10.1038/bcj.2015.28 |
Ejemplares similares
-
Waldenstrom macroglobulinemia: prognosis and management
por: Oza, A, et al.
Publicado: (2016) -
How to manage Waldenstrom's macroglobulinemia
por: Buske, C, et al.
Publicado: (2013) -
New developments in the management of Waldenström macroglobulinemia
por: Abeykoon, Jithma P, et al.
Publicado: (2017) -
Managing Waldenström’s macroglobulinemia with BTK inhibitors
por: Buske, Christian, et al.
Publicado: (2022) -
Waldenstrom’s Macroglobulinemia: An Update
por: Mazzucchelli, Maddalena, et al.
Publicado: (2018)